Picture of Transcat logo

TRNS Transcat Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-18.92%
3m+1.1%
6m-2.94%
1yr+7.92%
Volume Change (%)
10d/3m-7.04%
Price vs... (%)
52w High-18.65%
50d MA+0.07%
200d MA+12.41%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)55.65
PEG Ratio (f)3.53
EPS Growth (f)18.69%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.85
Price to Tang. Book10.97
Price to Free Cashflow56.49
Price to Sales4.21
EV to EBITDA31.84

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.79%
Return on Equity8.4%
Operating Margin7.62%

Financial Summary

Year End 30th MarUnit202020212022202320242025E2026ECAGR / Avg
Total Revenue$m173.1173.34204.96230.57259.48292.93311.1110.03%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+13.26+1.95+44.36-11.54+22.54+18.51+19.19n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Mar 202530th Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Transcat EPS forecast chart

Profile Summary

Transcat, Inc. is a provider of accredited calibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test, measurement, and control instrumentation. The Company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses. Through its Service segment, it offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services, a majority of which are processed through its asset management system, CalTrak, and its online customer portal, C3. It also provides permanent and periodic onsite services, mobile calibration services, pickup and delivery and in-house services. Through its Distribution segment, it sells and rents national and proprietary brand instruments to customers globally.

Directors

Last Annual
March 30th, 2024
Last Interim
March 30th, 2024
Incorporated
March 19th, 1964
Public Since
July 5th, 1965
No. of Shareholders
500
No. of Employees
1,104
Sector
Electronic Equipments & Parts
Industry
Technology
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
9,133,823

TRNS Share Price Performance

Upcoming Events for TRNS

Q1 2025 Transcat Inc Earnings Release

Transcat Inc Annual Shareholders Meeting

Q2 2025 Transcat Inc Earnings Release

Similar to TRNS

Picture of Applied Optoelectronics logo

Applied Optoelectronics

us flag iconNASDAQ Global Market

Picture of Microvision logo

Microvision

us flag iconNASDAQ Global Market

FAQ